Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge
Si Sun(Wuhan University), Shan Guan(Army Medical University), Ping Cheng(Army Medical University), Quanming Zou(Army Medical University), Changchun Tu(Academy of Military Medical Sciences), Yangxue Ou(Army Medical University), Entao Li(University of Science and Technology of China), Bruno Pitard(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Qianfei Zuo(Army Medical University), Joseph Rosenecker(Ludwig-Maximilians-Universität München), Ping Luo(Army Medical University), Dongshui Lu(Army Medical University), Larry Cai(The University of Queensland), Yuan Ding, Chao Li(Eli Lilly (United States)), Bin Wang(Qingdao University), Yan Liu(Changchun Institute of Optics, Fine Mechanics and Physics), Chang Liu(Paul Scherrer Institute), Weijun Zhang(Army Medical University), Jie Tang(East China Normal University), Haibo Li(Army Medical University), Gan Zhao(Shanghai Medical College of Fudan University), Cheng Sui, Yuwei Gao(Changchun University of Chinese Medicine), Chuanfei Xu(Army Medical University)
Cited by 24
Related Papers
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k